Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian, Christine Guo; Xu, Yufei; Ceol, Craig; Wu, Feizhen; Larson, Allison; Dresser, Karen; Xu, Wenqi; Tan, Li; Hu, Yeguang; Zhan, Qian; Lee, Chung-Wei; Hu, Di; Lian, Bill Q; Kleffel, Sonja; Yang, Yijun; Neiswender, James; Khorasani, Abraham J; Fang, Rui; Lezcano, Cecilia; Duncan, Lyn M; Scolyer, Richard A; Thompson, John F; Kakavand, Hojabr; Houvras, Yariv; Zon, Leonard I; Mihm, Martin C; Kaiser, Ursula B; Schatton, Tobias; Woda, Bruce A; Murphy, George F; Shi, Yujiang G.
; 150(6): 1135-46, 2012 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-22980977
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Risk factors: riddle of the rays.
Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray.
CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
Unscheduled Visits of Patients with Familial Melanoma to a Pigmented Lesion Clinic: Evaluation of Patients' Characteristics and Suspicious Lesions.
Reduction in nevus biopsies in patients monitored by total body photography.
Pseudomelanomas Following Stevens-Johnson Syndrome.
Epidermal nevus syndromes: New insights into whorls and swirls.
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.